A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis
Clinical trial NCT03210961 · COMPLETED
Trial details
- NCT number
- NCT03210961
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-14
- Primary completion
- 2019-01-25
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.